Corpus Intelligence IC Memo — WESTERN STATE HOSPITAL 2026-04-26 09:35 UTC
IC Memo — WESTERN STATE HOSPITAL
Investment Committee Memorandum | KY | 163 beds | Grade C | EBITDA uplift $2.1M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

WESTERN STATE HOSPITAL

CCN 184002 | CHRISTIAN, KY | 163 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

WESTERN STATE HOSPITAL is a 163-bed under-performing / distressed in CHRISTIAN, KY with $28.8M in net patient revenue and a -100.0% operating margin. The hospital serves a payer mix of 5.4% Medicare, 3.4% Medicaid, and 91.2% commercial.

Thesis: Undervalued. Our ML models identify $2.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -100.0% to -128.6% (+736bps).

Net Revenue HCRIS$28.8M
Current EBITDA COMPUTED$-39.1M
Operating Margin COMPUTED-100.0%
Occupancy HCRIS87.7%
Revenue / Bed COMPUTED$177K
Net-to-Gross HCRIS43.9%
Distress Probability ML41.6%

2. Market Context & Competitive Position

114
KY Hospitals
-0.6%
State Median Margin
35
Comparable Hospitals

KY has 114 Medicare-certified hospitals with a median operating margin of -0.6%. The target's margin of -100.0% places it below the state median. Among 35 size-comparable peers (82-326 beds), the median margin is 0.1%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (82-326), prioritizing same-state peers. 35 hospitals in the comp set.

HospitalStateBedsRevenueMargin
WESTERN STATE HOSPITAL (Target)KY163$28.8M-100.0%
OWENSBORO HEALTH REGIONAL HOSPKY302$678.6M11.1%
BAPTIST HEALTH HARDINKY259$459.5M-1.5%
THE MEDICAL CENTERKY310$451.0M4.2%
BAPTIST HEALTH PADUCAHKY190$391.7M-0.5%
SAINT JOSEPH HOSPITALKY252$322.8M-17.3%
MERCY HEALTH LOURDES HOSPITAL KY178$288.1M7.7%
BAPTIST HEALTH CORBINKY197$285.4M1.4%
LAKE CUMBERLAND REGIONAL HOSPKY179$278.7M5.6%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.1M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$605K+210bp18mo
Cost to Collect4.5%2.5%$576K+200bp12mo
Denial Rate Reduction12.0%6.5%$570K+198bp12mo
A/R Days Reduction5200.0%3800.0%$350K+122bp9mo
Clean Claim Rate88.0%96.0%$18K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$605K
Cost to Collect
$576K
Denial Rate Reduction
$570K
A/R Days Reduction
$350K
Clean Claim Rate
$18K
Total EBITDA Uplift$2.1M
Current EBITDA$-39.1M
+ RCM Uplift+$2.1M
Pro Forma EBITDA$-37.0M
Current Margin-100.0%
Pro Forma Margin-128.6%
WC Released (1x)$1.1M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-60.2M$-237.0M0.00x-100.0%
Base (11x exit)10.0x11.0x$-60.2M$-280.3M0.00x-100.0%
Bull Case9.0x11.0x$-54.2M$-292.8M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-54.2M$-335.4M0.00x-100.0%
Bear Case11.0x10.0x$-66.2M$-228.0M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-66.2M$-272.4M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 35 hospitals with 82-326 beds
  • Same-state prioritization (n=36)
  • Comp margins: P25=-9.1% / P50=0.1% / P75=8.3%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.